Bristol Myers Squibb Co. (BMY)
66.52
-0.43
(-0.64%)
USD |
NYSE |
Aug 28, 15:42
Bristol Myers Squibb Debt to Equity Ratio : 2.019 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.019 |
| March 31, 2026 | 2.314 |
| December 31, 2025 | 2.552 |
| September 30, 2025 | 2.751 |
| June 30, 2025 | 2.921 |
| March 31, 2025 | 2.947 |
| December 31, 2024 | 3.134 |
| September 30, 2024 | 2.998 |
| June 30, 2024 | 3.174 |
| March 31, 2024 | 3.481 |
| December 31, 2023 | 1.409 |
| September 30, 2023 | 1.354 |
| June 30, 2023 | 1.226 |
| March 31, 2023 | 1.237 |
| December 31, 2022 | 1.311 |
| September 30, 2022 | 1.228 |
| June 30, 2022 | 1.320 |
| March 31, 2022 | 1.456 |
| December 31, 2021 | 1.268 |
| September 30, 2021 | 1.232 |
| June 30, 2021 | 1.258 |
| March 31, 2021 | 1.257 |
| December 31, 2020 | 1.366 |
| September 30, 2020 | 0.9133 |
| June 30, 2020 | 0.9677 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.9523 |
| December 31, 2019 | 0.9213 |
| September 30, 2019 | 1.447 |
| June 30, 2019 | 1.593 |
| March 31, 2019 | 0.4327 |
| December 31, 2018 | 0.5238 |
| September 30, 2018 | 0.5357 |
| June 30, 2018 | 0.5997 |
| March 31, 2018 | 0.6019 |
| December 31, 2017 | 0.6781 |
| September 30, 2017 | 0.5711 |
| June 30, 2017 | 0.559 |
| March 31, 2017 | 0.585 |
| December 31, 2016 | 0.4147 |
| September 30, 2016 | 0.4372 |
| June 30, 2016 | 0.4515 |
| March 31, 2016 | 0.4657 |
| December 31, 2015 | 0.4689 |
| September 30, 2015 | 0.4824 |
| June 30, 2015 | 0.4873 |
| March 31, 2015 | 0.4797 |
| December 31, 2014 | 0.5273 |
| September 30, 2014 | 0.5064 |
| June 30, 2014 | 0.5048 |
| March 31, 2014 | 0.4943 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
| Merck & Co., Inc. | 1.286 |
| Pfizer Inc. | 0.7418 |
| AstraZeneca PLC | 0.7166 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 87.63B |
| Total Liabilities (Quarterly) | 65.32B |
| Shareholders Equity (Quarterly) | 22.32B |
| Current Ratio | 1.532 |
| Net Debt Paydown Yield | 1.05% |